Antipsychotic Roundup 2008

June, 2008 | Vol: 6 Issue: 6

In this issue

Learning Objective



You’ve probably heard about Fanapta (iloperidone), a new antipsychotic marketed by Vanda Pharmaceuticals. No, it hasn’t been approved officially yet, but it is likely to win approval in July, and the company has already been taking out teaser ads in the journals and has even sponsored a touring promotional CME program run by Stephen Stahl.

Antipsychotic Updates

Here is some selective coverage of interesting recent developments in antipsychotic medications.

Research Update

Tales From History

Expert QA